[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
April 22, 1983

Follow-up of the Cancer Patient

Author Affiliations

Northwestern University Medical School and Cancer Center Chicago

JAMA. 1983;249(16):2239-2240. doi:10.1001/jama.1983.03330400083039

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Contemporary treatment by an oncologist is presumed to have preceded the starting point of this text. The editors have allowed no indulgence in speculative measures; for example, adjuvant chemotherapy is considered at points where it is of demonstrable value or noted as a question for research protocol.

At several points, particularly in the follow-up of successfully treated neoplasms, greater concern for nonneoplastic or second primary neoplastic disease should be demonstrated. The toxic effects of therapy should also be in diagnostic differentials. The one flawed chapter was that on breast cancer, where a unimodal surgical approach mentioned neither a combined modality treatment option with radiation therapy, nor any role for postprimary treatment, adjuvant chemotherapy.

Diligent editing has eliminated redundancy in the brief chapters, all four to six pages devoted to each tumor type. The editorial belief that the nononcologist can provide excellent and cost-effective follow-up seems fulfilled in all solid-tumor areas.

First Page Preview View Large
First page PDF preview
First page PDF preview